SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Rizvi Syed Ali-aamir

(Last) (First) (Middle)
C/O CARIBOU BIOSCIENCES, INC.
2929 7TH STREET, SUITE 105

(Street)
BERKELEY CA 94710

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/18/2022
3. Issuer Name and Ticker or Trading Symbol
Caribou Biosciences, Inc. [ CRBU ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Medical Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 5,000 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 Power of Attorney
/s/ Barbara G. McClung, as attorney-in-fact 01/24/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                                                                   Exbibit 24

                                 POWER OF ATTORNEY

      With respect to holdings of and transactions in securities issued by
Caribou Biosciences, Inc. (the "Company"), the undersigned hereby constitutes
and appoints the individuals named on Schedule A attached hereto and as may be
amended from time to time, or any of them signing singly, with full power of
substitution and resubstitution, to act as the undersigned's true and lawful
attorney-in-fact to:

     1.   execute for and on behalf of the undersigned, Schedules 13D and 13G
          in accordance with Section 13 of the Securities Exchange Act of
          1934, as amended (the "Exchange Act"), and the rules thereunder, and
          Forms 3,4, and 5 in accordance with Section 16 of the Exchange Act
          and the rules thereunder;


     2.    do and perform any and all acts for and on behalf of the
           undersigned which may be necessary or desirable to complete and
           execute any such Schedule 13D or 13G or Form 3, 4, or 5, complete
           and execute any amendment or amendments thereto, and timely file
           such schedule or form with the SEC and any stock exchange or
           similar authority; and

    3.     take any other action of any type whatsoever in connection with
           the foregoing which, in the opinion of such attorney-in-fact, may
           be of benefit to, in the best interest of, or legally required by,
           the undersigned, it being understood that the documents executed
           by such attorney-in-fact on behalf of the undersigned pursuant to
           this Power of Attorney shall be in such form and shall contain
           such terms and conditions as such attorney-in-fact may approve in
           such attorney-in-fact's discretion.


       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution and resubstitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorneys-in-fact
substitute or substitutes, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted.

       The  undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 13 and Section 16 of the Exchange Act.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Schedule 13D and 13G and Forms 3, 4,
and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 1st day of November, 2021.

                                                     /s/ Syed Rizvi
                                                     ------------------------

                                   Schedule  A

Individuals Appointed as Attorney-in-Fact with Full Power of Substitution and
Resubstitution


1.    Rachel E. Haurwitz
2.    Barbara G. McClung
3.    Jason V. O'Byrne
4.    Ryan Fischesser